Article Versions Notes

Đorđević V, Petković M, Živković J, Nikolić GM, Veselinović AM. Development of Novel Therapeutics for Schizophrenia Treatment Based on a Selective Positive Allosteric Modulation of α1-Containing GABAARs—In Silico Approach. Current Issues in Molecular Biology. 2022; 44(8):3398-3412. https://doi.org/10.3390/cimb44080234

Đorđević, Vladimir, Milan Petković, Jelena Živković, Goran M. Nikolić, and Aleksandar M. Veselinović. 2022. "Development of Novel Therapeutics for Schizophrenia Treatment Based on a Selective Positive Allosteric Modulation of α1-Containing GABAARs—In Silico Approach" Current Issues in Molecular Biology 44, no. 8: 3398-3412. https://doi.org/10.3390/cimb44080234

Đorđević, V., Petković, M., Živković, J., Nikolić, G. M., & Veselinović, A. M. (2022). Development of Novel Therapeutics for Schizophrenia Treatment Based on a Selective Positive Allosteric Modulation of α1-Containing GABAARs—In Silico Approach. Current Issues in Molecular Biology, 44(8), 3398-3412. https://doi.org/10.3390/cimb44080234